It was shown that 30 μM EGCG inhibited the activation of mitogen-activated protein kinases 1 and 3 (MAPK1 and MAPK3) in colon cancer cell line HT29 [73]. This evidence concerns the gene MAPK1 and malignant colon neoplasm.